STOCK TITAN

Merus N.V - MRUS STOCK NEWS

Welcome to our dedicated news page for Merus N.V (Ticker: MRUS), a resource for investors and traders seeking the latest updates and insights on Merus N.V.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Merus N.V's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Merus N.V's position in the market.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.3%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.04%
Tags
none
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
28.28%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.63%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.88%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.06%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.56%
Tags
Merus N.V

Nasdaq:MRUS

MRUS Rankings

MRUS Stock Data

2.46B
42.51M
7.18%
88.09%
5.89%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Netherlands
Utrecht

About MRUS

merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. our most advanced development programs use the biclonics® format. biclonics® are capable of simultaneously attacking tumors in multiple ways. for example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways.